Search

Home > GRACEcast Lung Cancer Video > New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1
Podcast: GRACEcast Lung Cancer Video
Episode:

New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1
Category: Science & Medicine
Duration: 00:31:43
Publish Date: 2016-01-01 17:07:20
Description:

Xalkori (critzotinib) was the first approved treatment for ALK+ and ROS1 lung cancer. Since then, other drugs have been approved or are currently undergoing scientific review. In this video, Dr. Owonikoko outlines these options for patients.
Total Play: 0